PressRoom
Welcome to the Snoasis Medical PressRoom page. Here you will find all of the latest news, information, and updates about Snoasis Medical, BioCover, and future products.
Commercialization of BioXclude – Mar 2010
Snoasis Medical, Inc. introduces BioXclude, a processed, dehydrated and terminally sterilized graft composed of human amnion and chorion tissue. BioXclude represents the first allograft sourced from donated placental tissue for use as a wound covering in guided bone regeneration procedures.
BioCover Selected Editors Choice – Aug 2009
BioCover was selected as the Editor’s Choice for New Products in the August 2009 issue of Dental Products Report.
Allograft Platelet Derived Protein Licensing Agreement – Aug 2009
Snoasis Medical completed a licensing agreement with the University of Colorado for the world-wide, exclusive dental rights to Allograft Platelet Derived Protein (APDP); a new growth factor solution unlike anything on the market today.
Commercialization of BioCover – June 2009
Snoasis Medical Inc. announces commercialization of BioCover™, the first allograft sourced from amnion tissue for use as a wound covering in the treatment of gingival recession.
Partnership with Surgical Biologics – July 2008
Snoasis Medical Inc. and Surgical Biologics complete a licensing, manufacturing, and distribution agreement.